Cilgavimab
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556) . Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection[1].
Product Specifications
CAS Number
[2420563-99-9]
Product Name Alternative
AZD-1061; COV2-2130
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cilgavimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Cilgavimab]
Molecular Weight
(148.82 kDa)
References & Citations
[1]Levin MJ, et al; PROVENT Study Group. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19. N Engl J Med. 2022 Jun 9;386 (23) :2188-2200. |[2]Zost SJ, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 Aug;584 (7821) :443-449.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6474725-01 0.1 mL
ErbB2, phosphorylated, Tyr1248 (c-erbB2, HER2, neu Oncoprotein) (APC)
Ask
View Details 
MBS6474725-02 5x 0.1 mL
ErbB2, phosphorylated, Tyr1248 (c-erbB2, HER2, neu Oncoprotein) (APC)
Ask
View Details